Kane Biotech Inc. V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.

TSXV:KNE - Post by User

Kane Biotech Inc.

Bullboard Posts

Comment by casseon May 03, 2014 8:53am

301 Views

Post# 22520786

RE:RE:RE:RE:RE:RE:Insider Trade Details

In fact I was wrong, since 2014/02/06 the new president is Philip Renaud.
To answer your question and now knowing that he is the new president I would assume that yes any future sales will be considered as insider (but it is just my guess, I may be wrong)

From Registraire des entreprises du Quebec
Liste des administrateurs

Nom de famille CREVIER
Prénom DAVID

Date du début de la charge 2010/09/21

Fonctions actuelles Secrétaire

Nom de famille RENAUD
Prénom PHILIP
Date du début de la charge 2014/02/06
Fonctions actuelles Président

Bullboard Posts

Morning Market Outlook for July 3, 2024